Foslinanib( TRX-818 | TRX818 )

Catalog No. M11045 CAS No. 1256037-60-1

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

Foslinanib
Note

Research use only, not for human use.
Brief Description

Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
Description

Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action.Liver Cancer Phase 2 Clinical
In Vitro

——
In Vivo

——
Synonyms

TRX-818 | TRX818
Pathway

Others
Target

Other Targets
Recptor

Other Targets
Research Area

Cancer
Indication

Liver Cancer

CAS Number

1256037-60-1
Formula Weight

365.253
Molecular Formula

C16H13FNO6P
Purity

>98% (HPLC)
Solubility

——
SMILES

O=P(O)(OC1=C(OC)C=CC(NC(C2=CC=CC(F)=C2)=C3)=C1C3=O)O
Chemical Name

2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin5-yl dihydrogen phosphate